Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

Recombinant Human GUCY1A2 Protein, N-His

Recombinant Human GUCY1A2 Protein, N-Hisexpressed in E. coli , spanning Ser496-Arg700. Purity: >90% by SDS-PAGE. Highlights His-Tagged: N-terminal 6xHis tag for IMAC purification. E. coli Expression: High-yield, cost-effective production. High Purity: >90% purity verified by SDS-PAGE.

Product Specifications

Product Name Alternative

Guanylate cyclase soluble subunit alpha-2, GCS-alpha-2, 4.6.1.2, GUCY1A2, GUC1A2, GUCSA2

UniProt

P33402

Expression Region

Ser496-Arg700

Origin

Homo sapiens (Human)

Endotoxin

Please contact with the lab for this information.

Purity

>90% as determined by SDS-PAGE.

Form

Lyophilized

Molecular Weight

25.39 kDa

Storage Conditions

-20°C

Notes

For research use only.

Tested Applications

ELISA, SDS-PAGE, WB

Preservative

Lyophilized from a solution in PBS pH 7.4, 0.02% NLS, 1mM EDTA, 4% Trehalose, 1% Mannitol.

Available Sizes

Frequently Asked Questions

More Discoveries

Explore Other Products

Browse additional items from our catalog

JOSD1 Protein Vector (Mouse) (pPB-N-His)
PV192983 500 ng

JOSD1 Protein Vector (Mouse) (pPB-N-His)

Sign In for Pricing
View Details
Hepatitis B Virus Surface Antigen Antibody-FITC labled
E51A10100 100 µL

Hepatitis B Virus Surface Antigen Antibody-FITC labled

Sign In for Pricing
View Details
Human SH2-containing protein (SHC/SLP-76) ELISA Kit
QY-E04600 96 Tests

Human SH2-containing protein (SHC/SLP-76) ELISA Kit

Sign In for Pricing
View Details
C14orf43 sgRNA CRISPR Lentivector (Human) (Target 3)
K0298004 1.0 µg DNA

C14orf43 sgRNA CRISPR Lentivector (Human) (Target 3)

Sign In for Pricing
View Details
Thymopoietin i/ii (29-41) (bovine)
HY-P3967 1 Each

Thymopoietin i/ii (29-41) (bovine)

Sign In for Pricing
View Details
Reagecon Holmium Perchlorate Solution according to European Pharmacopoeia (EP) Chapter 4 (4.1.1)
1043101 1 L

Reagecon Holmium Perchlorate Solution according to European Pharmacopoeia (EP) Chapter 4 (4.1.1)

Sign In for Pricing
View Details